Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

By A. Leizorovicz, A. Cohen, A. Turpie, C. Olsson, P. Vaitkus, Samuel Z. Goldhaber. Circulation, 2004

960 citations recorded by the source corpus.

Subfields: Hematology, Internal Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/1ccb5cd21b3ba56f96790cc133108f0aee8f17da

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. M. Cushman
2. S. Konstantinides

In Internal Medicine

1. M. Cushman
2. Samuel Z. Goldhaber
3. S. Konstantinides

In Surgery

1. M. Cushman
2. Joshua A. Beckman

Citations in the corpus

• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “Prophylactic anticoagulation reduces the risk of VTE in acutely ill hospitalized medical patients (50-52), and appropriate use of VTE prophylaxis is covered in clinical practice guidelines (49,53,54).”